Status:
COMPLETED
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Lead Sponsor:
Boston University Charles River Campus
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Anxiety Disorders
Mood Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Anxiety disorders are common, chronic, costly, debilitating to quality of life, and are more prevalent than any other class of disorders in every country in the world where surveys have been taken. De...
Detailed Description
The purpose of this proposal is to evaluate efficacy of the recently developed Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP). This protocol takes advantage of recent advan...
Eligibility Criteria
Inclusion
- For inclusion, subjects will be males and females 18 years or older, fluent in the English language who have a principal DSM-IV diagnosis of SAD, PD/A, GAD, or OCD. In addition, to be eligible for participation, individuals must be willing to refrain from initiating additional treatment during the course of therapy unless mutually agreed upon with the therapists and the principal investigator; and willing to be randomly assigned to treatment conditions.
Exclusion
- Patients will be excluded if they meet any of the following criteria:
- Current DSM-IV diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or organic mental disorder.
- Clear and current suicidal risk.
- Current or recent (past 90 days) history of substance abuse or drug dependence, with the exception of nicotine, marijuana, and caffeine.
- Individuals will also be excluded if they previously received an adequate trial of CBT or if their emotional symptomatology is due to a medical/physical condition in which case alternative treatment would be clinically indicated.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01243606
Start Date
December 1 2010
End Date
May 1 2017
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Anxiety and Related Disorders at Boston University
Boston, Massachusetts, United States, 02215